Stanley Capital to buy Noden from PDL BioPharma
PDL BioPharma Inc has agreed to sell Noden to Stanley Capital for up to $48.25 million in cash.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
